Nasdaq · CIK 0000718937
STAA STAAR SURGICAL CO
Insider trading from SEC Form 4. Last filing Jun 22, 2026. Close $21.67 on Oct 9, 2026, +35% from the 52-week low and -35% from the high.
STAAR SURGICAL CO (STAA) has 49 SEC Form 4 filings on file from 8 insiders, the latest filed on Jun 22, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
15 open-market trades have been scored at STAA. The newest: Broadwood Partners, L.p. (director and 10% owner) bought $12M of stock on Mar 11, 2026, filed Mar 13, 2026, scored 53 (moderate). The largest of the 15 shown: Broadwood Partners, L.p. (10% owner) bought $41M on Nov 19, 2025, scored 35 (weak).
STAA closed at $21.67 on Oct 9, 2026, 35% above its 52-week low and 35% below its 52-week high.
2 Form 144 notices of planned sales are on file, the latest filed Aug 5, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at STAAR SURGICAL CO, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Broadwood Partners, L.p. director, owner buy | $12M 670,213 shares | +4% | +17% from low-38% from high | |
| 30Weak | Broadwood Partners, L.p. owner buy | $606k 27,485 shares | +0% | +47% from low-23% from high | |
| 41Moderate | Broadwood Partners, L.p. owner buy | $8.8M 406,653 shares | +3% | +48% from low-22% from high | |
| 35Weak | Broadwood Partners, L.p. owner buy | $41M 1,500,000 shares | +11% | +75% from low-9% from high | |
| 55Moderate | Broadwood Partners, L.p. owner buy | $2.9M 187,227 shares | +1% | 0% from low-59% from high | |
| 48Moderate | Broadwood Partners, L.p. owner buy | $14M 845,220 shares | +7% | +13% from low-53% from high | |
| 39Weak | Broadwood Partners, L.p. owner buy | $941k 53,969 shares | +0% | +15% from low-53% from high | |
| 40Moderate | Broadwood Partners, L.p. owner buy | $2.0M 113,384 shares | +1% | +14% from low-53% from high | |
| 45Moderate | Broadwood Partners, L.p. owner buy | $2.4M 136,696 shares | +1% | +15% from low-52% from high | |
| 45Moderate | Broadwood Partners, L.p. owner buy | $3.6M 201,844 shares | +2% | +19% from low-51% from high | |
| 25Weak | Broadwood Partners, L.p. owner buy | $482k 27,953 shares | +0% | - | |
| 40Moderate | Broadwood Partners, L.p. owner buy | $11M 663,761 shares | +6% | - | |
| 37Weak | Broadwood Partners, L.p. owner buy | $6.3M 411,430 shares | +4% | - | |
| 27Weak | Broadwood Partners, L.p. owner buy | $631k 29,376 shares | +0% | - | |
| 27Weak | Broadwood Partners, L.p. owner buy | $1.9M 80,200 shares | +1% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 5, 2025 | WEISNER AIMEE S Former Director | 13,491 0.03% of outstanding | $363k | Aug 5, 2025 | none |
| Aug 5, 2025 | WEISNER AIMEE S Former Director | 1,750 0.00% of outstanding | $47k | Aug 5, 2025 | none |
Transactions
The newest 50 of 177 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Wei Jiang director | MOption exercise Common Stock | +10,683 | $0.00 | $0 | 77,127 | Jun 22, 2026 |
| Jun 18, 2026 | Arthur C Butcher director | MOption exercise Common Stock | +5,341 | $0.00 | $0 | 9,549 | Jun 22, 2026 |
| Jun 18, 2026 | Richard T. LeBuhn director | AGrant or award OPTION TO PURCHASE COMMON STOCKderivative | +11,145 | $0.00 | $0 | 11,145 | Jun 22, 2026 |
| Jun 18, 2026 | Neal C Bradsher director, owner | AGrant or award OPTION TO PURCHASE COMMON STOCKderivative | +11,145 | $0.00 | $0 | 11,145 | Jun 22, 2026 |
| Jun 18, 2026 | Arthur C Butcher director | MOption exercise Restricted Stock Unitsderivative | -5,341 | $0.00 | $0 | 0 | Jun 22, 2026 |
| Jun 18, 2026 | Wei Jiang director | MOption exercise Restricted Stock Unitsderivative | -10,683 | $0.00 | $0 | 0 | Jun 22, 2026 |
| Jun 18, 2026 | Arthur C Butcher director | AGrant or award Common Stock Optionsderivative | +4,458 | $0.00 | $0 | 4,458 | Jun 22, 2026 |
| Jun 18, 2026 | Wei Jiang director | AGrant or award Restricted Stock Unitsderivative | +6,182 | $0.00 | $0 | 6,182 | Jun 22, 2026 |
| Jun 18, 2026 | Arthur C Butcher director | AGrant or award Restricted Stock Unitsderivative | +3,709 | $0.00 | $0 | 3,709 | Jun 22, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | AGrant or award Common Stock | +14,662 | $0.00 | $0 | 81,579 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | AGrant or award Common Stock | +10,466 | $0.00 | $0 | 10,466 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | FTax withholding Common Stock | -3,755 | $32.07 | $120k | 15,297 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | FTax withholding Common Stock | -7,460 | $32.07 | $239k | 74,119 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | AGrant or award Common Stock | +7,331 | $0.00 | $0 | 81,450 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | AGrant or award Common Stock | +5,233 | $0.00 | $0 | 20,530 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | FTax withholding Common Stock | -3,730 | $32.07 | $120k | 77,720 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | FTax withholding Common Stock | -1,877 | $32.07 | $60k | 18,653 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | AGrant or award Common Stock | +7,331 | $0.00 | $0 | 85,051 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | MOption exercise Performance Stock Unitsderivative | +10,466 | $0.00 | $0 | 10,466 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | FTax withholding Common Stock | -3,730 | $32.07 | $120k | 81,321 | May 19, 2026 |
| May 15, 2026 | Deborah J Andrews Interim Co-CEO and CFO | MOption exercise Performance Stock Unitsderivative | +5,233 | $0.00 | $0 | 15,699 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | AGrant or award Common Stock | +3,666 | $0.00 | $0 | 84,987 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | FTax withholding Common Stock | -1,865 | $32.07 | $60k | 83,112 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Performance Stock Unitsderivative | +14,662 | $0.00 | $0 | 14,662 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Performance Stock Unitsderivative | +7,331 | $0.00 | $0 | 21,993 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Performance Stock Unitsderivative | +7,331 | $0.00 | $0 | 29,324 | May 19, 2026 |
| May 15, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Performance Stock Unitsderivative | +3,666 | $0.00 | $0 | 32,990 | May 19, 2026 |
| May 8, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | FTax withholding Common Stock | -3,448 | $26.69 | $92k | 66,917 | May 12, 2026 |
| Mar 13, 2026 | Deborah J Andrews Interim Co-CEO and CFO | AGrant or award Restricted Stock Unitsderivative | +39,809 | $0.00 | $0 | 39,809 | Mar 16, 2026 |
| Mar 12, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Common Stock | +8,175 | $0.00 | $0 | 34,263 | Mar 16, 2026 |
| Mar 12, 2026 | Magda Michna Chief Development Officer | MOption exercise Common Stock | +6,178 | $0.00 | $0 | 20,622 | Mar 16, 2026 |
| Mar 12, 2026 | Magda Michna Chief Development Officer | FTax withholding Common Stock | -2,216 | $18.39 | $41k | 18,406 | Mar 16, 2026 |
| Mar 14, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Common Stock | +19,550 | $0.00 | $0 | 53,813 | Mar 16, 2026 |
| Mar 14, 2026 | Magda Michna Chief Development Officer | MOption exercise Common Stock | +14,663 | $0.00 | $0 | 33,069 | Mar 16, 2026 |
| Mar 14, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Common Stock | +9,775 | $0.00 | $0 | 63,588 | Mar 16, 2026 |
| Mar 14, 2026 | Magda Michna Chief Development Officer | MOption exercise Common Stock | +2,932 | $0.00 | $0 | 36,001 | Mar 16, 2026 |
| Mar 12, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Restricted Stock Unitsderivative | -8,175 | $0.00 | $0 | 8,175 | Mar 16, 2026 |
| Mar 14, 2026 | Magda Michna Chief Development Officer | FTax withholding Common Stock | -6,313 | $18.84 | $119k | 29,668 | Mar 16, 2026 |
| Mar 13, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | AGrant or award Restricted Stock Unitsderivative | +45,117 | $0.00 | $0 | 45,117 | Mar 16, 2026 |
| Mar 12, 2026 | Magda Michna Chief Development Officer | MOption exercise Restricted Stock Unitsderivative | -6,178 | $0.00 | $0 | 6,178 | Mar 16, 2026 |
| Mar 14, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Restricted Stock Unitsderivative | -19,550 | $0.00 | $0 | 39,101 | Mar 16, 2026 |
| Mar 14, 2026 | Warren Foust Interim Co-CEO and Pres. & COO | MOption exercise Restricted Stock Unitsderivative | -9,775 | $0.00 | $0 | 19,551 | Mar 16, 2026 |
| Mar 13, 2026 | Magda Michna Chief Development Officer | AGrant or award Restricted Stock Unitsderivative | +33,838 | $0.00 | $0 | 33,838 | Mar 16, 2026 |
| Mar 14, 2026 | Magda Michna Chief Development Officer | MOption exercise Restricted Stock Unitsderivative | -14,663 | $0.00 | $0 | 29,326 | Mar 16, 2026 |
| Mar 14, 2026 | Magda Michna Chief Development Officer | MOption exercise Restricted Stock Unitsderivative | -2,932 | $0.00 | $0 | 5,866 | Mar 16, 2026 |
| Mar 11, 2026 | Broadwood Partners, L.p. director, owner | POpen-market purchase Common Stock | +54,764 | $17.52 | $960k | 15,508,393 | Mar 13, 2026 |
| Mar 11, 2026 | Broadwood Partners, L.p. director, owner | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 15,508,393 | Mar 13, 2026 |
| Mar 12, 2026 | Broadwood Partners, L.p. director, owner | POpen-market purchase Common Stock | +299,432 | $18.12 | $5.4M | 15,807,825 | Mar 13, 2026 |
| Mar 12, 2026 | Broadwood Partners, L.p. director, owner | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 15,807,825 | Mar 13, 2026 |
| Mar 13, 2026 | Broadwood Partners, L.p. director, owner | POpen-market purchase Common Stock | +316,017 | $18.62 | $5.9M | 16,123,842 | Mar 13, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Deborah J AndrewsInterim Co-CEO and CFO
- Broadwood Partners, L.p.owner, director
- Neal C Bradsherowner, director
- Arthur C Butcherofficer, director
- Warren FoustInterim Co-CEO and Pres. & COO
- Wei Jiangdirector
- Richard T. LeBuhndirector
- Magda MichnaChief Development Officer
Questions about STAA
Answered from the filings on this page, as of the latest one.
Are insiders buying STAA?
No. In the last 90 days no insider at STAAR SURGICAL CO bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade STAA on the open market?
Broadwood Partners, L.p. (director and 10% owner) bought $12M of STAA on Mar 11, 2026 and filed the Form 4 on Mar 13, 2026. InsiderTell scored 53 (moderate).
How many insiders file Form 4 at STAAR SURGICAL CO?
8 people have filed a Form 4 at STAAR SURGICAL CO, among them Deborah J Andrews (Interim Co-CEO and CFO), Broadwood Partners, L.p. (10% owner and director), Neal C Bradsher (10% owner and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.